本論文利用具有解酒以及護肝功能的漢方食材葛花以及枳椇子搭配辣木籽粉組合成草藥配方GLJ，探討GLJ對於肝臟細胞發炎與小鼠急性酒精性肝損傷的保護作用。我們採用實驗小鼠作為動物實驗模式，分成空白處理組(Sham)、只有給予草藥配方GLJ處理組(GLJ)、只有給予急性酒精處理組(ALC)、以及餵食草藥配方GLJ後再給予急性酒精處理組(GLJ+ALC)。利用小鼠平衡桿行走、滾輪跑步、懸吊測試，以及抽血檢測血液中天門冬胺基酸胺基轉移酶(GOT)、丙胺基酸胺基轉移酶(GTP)、以及乳酸脫氫酶(LDH)生化值。此外檢視小鼠肝臟組織，來探討草藥配方GLJ對於急性酒精處理小鼠的行為異常與肝功能保護作用。實驗結果顯示：ALC組小鼠相較於Sham與GLJ組小鼠的運動以及平衡的表現明顯差；而GLJ+ALC組小鼠相較於ALC組小鼠的運動以及平衡的表現則顯著改善許多。此外，ALC組小鼠相較於Sham與GLJ組小鼠血液內GOT、GTP、LDH的數值明顯較高，並且具有急性酒精性肝損傷的情形；而GLJ+ALC組小鼠相較於ALC組小鼠血液內GOT、GTP、LDH的數值則顯著降低，而急性酒精性肝損傷的情形也顯著改善。綜合上述結果，我們認為草藥配方GLJ處理對於急性酒精處理的肝細胞發炎以及小鼠的肝損傷應該具有保護的作用。由於葛花、枳椇子、辣木籽均屬藥食同源的草藥食材，因此，應該可以作為預防急性酒精肝損傷的營養補充品。

In this paper, we used the herbal ingredients of flowers of kudzuvine (Pueraria phaseoloides (Roxb.) Benth.), seeds of raisin tree (Hovenia acerba Lindl.), and together with seeds of moringa (Moringa oleifera Lam.), which have anti-alcoholic and liver-protecting functions, to form herbal formula GLJ. Then we explored the protective effect of GLJ on acute alcoholic liver injury in mice. We used experimental mice as the animal experiment model. Mice were divided into blank treatment group (Sham), herbal formula GLJ treatment group (GLJ), acute alcohol treatment group (ALC), and acute alcohol treatment after feeding GLJ group (GLJ+ALC). We further studied the protective effects of GLJ on the behavior and liver dysfunction of acute alcohol-treated mice. Behavior dysfunction was examined by using wheel running, balance pole walking, and suspension tests. Liver dysfunction was examined by detecting biochemical value of aspartate aminotransferase (GOT), alanine aminotransferase (GTP), and lactate dehydrogenase (LDH) in blood, and examining liver tissue. Our results showed that the performance of movement and balance of the ALC mice group was significantly worse than that of the Sham and GLJ mice groups; compared with the ALC mice group, the performance of movement and balance of the GLJ+ALC mice group was significantly improved. In addition, compared with the the Sham and GLJ mice groups, the values of GOT, GTP, and LDH in the blood of the ALC mice group were increased significantly, and acute alcoholic liver injury occurred; while compared with the ALC mice group, the values of GOT, GTP, and LDH in the blood of the GLJ+ALC mice group were significantly reduced, and the situation of acute alcoholic liver injury was also significantly improved. Based on the above results, we believe that the herbal formula GLJ treatment should have a protective effect on acute alcohol treated liver cell inflammation and liver injury in mice. Thus, we suggested that herbal formula GLJ can be used as nutritional supplements to prevent acute alcoholic liver injury because they are homology of medicine and food.

Abdel Fattah, M. E., Sobhy, H. M., Reda, A., & Abdelrazek, H. M. A. (2020). Hepatoprotective effect of Moringa oleifera leaves aquatic extract against lead acetate-induced liver injury in male Wistar rats. Environmental science and pollution research international, 27(34), 43028–43043. https://doi.org/10.1007/s11356-020-10161-z
Abdel-Daim, M. M., Khalil, S. R., Awad, A., Abu Zeid, E. H., El-Aziz, R. A., & El-Serehy, H. A. (2020). Ethanolic Extract of Moringa oleifera Leaves Influences NF-κB Signaling Pathway to Restore Kidney Tissue from Cobalt-Mediated Oxidative Injury and Inflammation in Rats. Nutrients, 12(4), 1031. https://doi.org/10.3390/nu12041031
Addolorato, G., Mirijello, A., Barrio, P., & Gual, A. (2016). Treatment of alcohol use disorders in patients with alcoholic liver disease. Journal of hepatology, 65(3), 618–630. https://doi.org/10.1016/j.jhep.2016.04.029
An, L., Wang, X., & Cederbaum, A. I. (2012). Cytokines in alcoholic liver disease. Archives of toxicology, 86(9), 1337–1348. https://doi.org/10.1007/s00204-012-0814-6
Aragon, C. M., Rogan, F., & Amit, Z. (1992). Ethanol metabolism in rat brain homogenates by a catalase-H2O2 system. Biochemical pharmacology, 44(1), 93–98. https://doi.org/10.1016/0006-2952(92)90042-h
Aslam, M., Anwar, F., Nadeem, R., Rashid, U., Kazi, T., Nadeem, M. (2005). Mineral composition of Moringa Oleifera leaves and pods from different regions of Punjab, Pakistan. Asian J Plant Sci 4,417–421.
Becker, U., Deis, A., Sørensen, T. I., Grønbaek, M., Borch-Johnsen, K., Müller, C. F., Schnohr, P., & Jensen, G. (1996). Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology (Baltimore, Md.), 23(5), 1025–1029. https://doi.org/10.1002/hep.510230513
Bondy S. C. (1992). Ethanol toxicity and oxidative stress. Toxicology letters, 63(3), 231–241. https://doi.org/10.1016/0378-4274(92)90086-y
Cederbaum, A. I. (2012). Alcohol metabolism. Clinics in Liver Disease, 16(4), 667–685.
Chien, C. F., Wu, Y. T., & Tsai, T. H. (2011). Biological analysis of herbal medicines used for the treatment of liver diseases. Biomedical chromatography : BMC, 25(1-2), 21–38. https://doi.org/10.1002/bmc.1568
Choi, R. Y., Woo, M. J., Ham, J. R., & Lee, M. K. (2017). Anti-steatotic and anti-inflammatory effects of Hovenia dulcis Thunb. extracts in chronic alcohol-fed rats. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 90, 393–401. https://doi.org/10.1016/j.biopha.2017.03.077
Donnadieu-Rigole, H., Olive, L., Nalpas, B., Winter, A., Ursic-Bedoya, J., Faure, S., Pageaux, G. P., & Perney, P. (2017). Follow-Up of Alcohol Consumption After Liver Transplantation: Interest of an Addiction Team?. Alcoholism, clinical and experimental research, 41(1), 165–170. https://doi.org/10.1111/acer.13276
Frezza, M., di Padova, C., Pozzato, G., Terpin, M., Baraona, E., & Lieber, C. S. (1990). High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. The New England journal of medicine, 322(2), 95–99. https://doi.org/10.1056/NEJM199001113220205
Gyamfi, M. A., Yonamine, M., & Aniya, Y. (1999). Free-radical scavenging action of medicinal herbs from Ghana: Thonningia sanguinea on experimentally-induced liver injuries. General pharmacology, 32(6), 661–667. https://doi.org/10.1016/s0306-3623(98)00238-9
Haber, P. S., Warner, R., Seth, D., Gorrell, M. D., & McCaughan, G. W. (2003). Pathogenesis and management of alcoholic hepatitis. Journal of gastroenterology and hepatology, 18(12), 1332–1344. https://doi.org/10.1046/j.1440-1746.2003.03217.x
Halsted C. H. (2004). Nutrition and alcoholic liver disease. Seminars in liver disease, 24(3), 289–304. https://doi.org/10.1055/s-2004-832941
Hammoud, N., & Jimenez-Shahed, J. (2019). Chronic Neurologic Effects of Alcohol. Clinics in liver disease, 23(1), 141–155. https://doi.org/10.1016/j.cld.2018.09.010
Hyun, T. K., Eom, S. H., Yu, C. Y., & Roitsch, T. (2010). Hovenia dulcis--an Asian traditional herb. Planta medica, 76(10), 943–949. https://doi.org/10.1055/s-0030-1249776
Ishak, K. G., Zimmerman, H. J., & Ray, M. B. (1991). Alcoholic liver disease: pathologic, pathogenetic and clinical aspects. Alcoholism, clinical and experimental research, 15(1), 45–66. https://doi.org/10.1111/j.1530-0277.1991.tb00518.x
Kandeil, M. A., Mohammed, E. T., Hashem, K. S., Aleya, L., & Abdel-Daim, M. M. (2020). Moringa seed extract alleviates titanium oxide nanoparticles (TiO2-NPs)-induced cerebral oxidative damage, and increases cerebral mitochondrial viability. Environmental science and pollution research international, 27(16), 19169–19184. https://doi.org/10.1007/s11356-019-05514-2
Keung, W. M., & Vallee, B. L. (1998). Kudzu root: an ancient Chinese source of modern antidipsotropic agents. Phytochemistry, 47(4), 499–506. https://doi.org/10.1016/s0031-9422(97)00723-1
Khalil, S. R., Abdel-Motal, S. M., Abd-Elsalam, M., Abd El-Hameed, N. E., & Awad, A. (2020). Restoring strategy of ethanolic extract of Moringa oleifera leaves against Tilmicosin-induced cardiac injury in rats: Targeting cell apoptosis-mediated pathways. Gene, 730, 144272. https://doi.org/10.1016/j.gene.2019.144272
Kim, M. S., Ong, M., & Qu, X. (2016). Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?. World journal of gastroenterology, 22(1), 8–23. https://doi.org/10.3748/wjg.v22.i1.8
Kirpich, I. A., Miller, M. E., Cave, M. C., Joshi-Barve, S., & McClain, C. J. (2016). Alcoholic Liver Disease: Update on the Role of Dietary Fat. Biomolecules, 6(1), 1. https://doi.org/10.3390/biom6010001
Klatsky, A. L., & Armstrong, M. A. (1992). Alcohol, smoking, coffee, and cirrhosis. American journal of epidemiology, 136(10), 1248–1257. https://doi.org/10.1093/oxfordjournals.aje.a116433
Koch, O. R., Pani, G., Borrello, S., Colavitti, R., Cravero, A., Farrè, S., & Galeotti, T. (2004). Oxidative stress and antioxidant defenses in ethanol-induced cell injury. Molecular aspects of medicine, 25(1-2), 191–198. https://doi.org/10.1016/j.mam.2004.02.019
Kumar, P.S., Mishra, D., Ghosh, G., Panda, C.S. (2010). Medicinal uses and pharmacological properties of Moringa oleifera. International Journal of Phytomedicine, 2(3), 210-216. DOI: 10.5138/ijpm.2010.0975.0185.02031
Lee J. S. (2004). Supplementation of Pueraria radix water extract on changes of antioxidant enzymes and lipid profile in ethanol-treated rats. Clinica chimica acta; international journal of clinical chemistry, 347(1-2), 121–128. https://doi.org/10.1016/j.cccn.2004.04.002
Lee, H. U., Bae, E. A., & Kim, D. H. (2005). Hepatoprotective effect of tectoridin and tectorigenin on tert-butyl hyperoxide-induced liver injury. Journal of pharmacological sciences, 97(4), 541–544. https://doi.org/10.1254/jphs.scz040467
Lee, M. K., Cho, S. Y., Jang, J. Y., Cho, M. S., Jeon, S. M., Jang, M. K., Kim, M. J., & Park, Y. B. (2001). Effects of Puerariae Flos and Puerariae Radix extracts on antioxidant enzymes in ethanol-treated rats. The American journal of Chinese medicine, 29(2), 343–354. https://doi.org/10.1142/S0192415X01000368
Levy, R., Catana, A. M., Durbin-Johnson, B., Halsted, C. H., & Medici, V. (2015). Ethnic differences in presentation and severity of alcoholic liver disease. Alcoholism, clinical and experimental research, 39(3), 566–574. https://doi.org/10.1111/acer.12660
Li, H., Deng, Z., Liu, R., Young, J. C., Zhu, H., Loewen, S., & Tsao, R. (2011). Characterization of phytochemicals and antioxidant activities of a purple tomato (Solanum lycopersicum L.). Journal of agricultural and food chemistry, 59(21), 11803–11811. https://doi.org/10.1021/jf202364v
Lieber C. S. (2000). Alcoholic liver disease: new insights in pathogenesis lead to new treatments. Journal of hepatology, 32(1 Suppl), 113–128. https://doi.org/10.1016/s0168-8278(00)80420-1
Lieber C. S. (2004). Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol (Fayetteville, N.Y.), 34(1), 9–19. https://doi.org/10.1016/j.alcohol.2004.07.008
Lu, K. H., Liu, C. T., Raghu, R., & Sheen, L. Y. (2012). Therapeutic potential of chinese herbal medicines in alcoholic liver disease. Journal of traditional and complementary medicine, 2(2), 115–122. https://doi.org/10.1016/s2225-4110(16)30084-0
Lucey M. R. (2014). Liver transplantation for alcoholic liver disease. Nature reviews. Gastroenterology & hepatology, 11(5), 300–307. https://doi.org/10.1038/nrgastro.2013.247
Lz, A., Sx, A., Zo, A., Cm, A., Xy, A., Lin, H. A., Ym, A., Zl, B., Zy, A., & Lw, A. (2019). Gamma-oryzanol prevents ethanol-induced liver injury by ameliorating oxidative stress and modulating apoptosis-related protein expression in mice. Journal of Functional Foods, 62, 103532-103532.
Manguro, L. O., & Lemmen, P. (2007). Phenolics of Moringa oleifera leaves. Natural product research, 21(1), 56–68. https://doi.org/10.1080/14786410601035811
Masson, S., Emmerson, I., Henderson, E., Fletcher, E. H., Burt, A. D., Day, C. P., & Stewart, S. F. (2014). Clinical but not histological factors predict long-term prognosis in patients with histologically advanced non-decompensated alcoholic liver disease. Liver international : official journal of the International Association for the Study of the Liver, 34(2), 235–242. https://doi.org/10.1111/liv.12242
Mathurin, P., Duchatelle, V., Ramond, M. J., Degott, C., Bedossa, P., Erlinger, S., Benhamou, J. P., Chaput, J. C., Rueff, B., & Poynard, T. (1996). Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology, 110(6), 1847–1853. https://doi.org/10.1053/gast.1996.v110.pm8964410
Mathurin, P., Louvet, A., Duhamel, A., Nahon, P., Carbonell, N., Boursier, J., Anty, R., Diaz, E., Thabut, D., Moirand, R., Lebrec, D., Moreno, C., Talbodec, N., Paupard, T., Naveau, S., Silvain, C., Pageaux, G. P., Sobesky, R., Canva-Delcambre, V., Dharancy, S., … Dao, T. (2013). Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial. JAMA, 310(10), 1033–1041. https://doi.org/10.1001/jama.2013.276300
Meier, P., & Seitz, H. K. (2008). Age, alcohol metabolism and liver disease. Current opinion in clinical nutrition and metabolic care, 11(1), 21–26. https://doi.org/10.1097/MCO.0b013e3282f30564
Mendenhall, C., Roselle, G. A., Gartside, P., & Moritz, T. (1995). Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two Veterans Administration Cooperative Studies. Alcoholism, clinical and experimental research, 19(3), 635–641. https://doi.org/10.1111/j.1530-0277.1995.tb01560.x
Mohammad, M. K., Zhou, Z., Cave, M., Barve, A., & McClain, C. J. (2012). Zinc and liver disease. Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition, 27(1), 8–20. https://doi.org/10.1177/0884533611433534
Mumenthaler, M. S., Taylor, J. L., O'Hara, R., & Yesavage, J. A. (1999). Gender differences in moderate drinking effects. Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism, 23(1), 55–64.
Pavlov, C. S., Casazza, G., Semenistaia, M., Nikolova, D., Tsochatzis, E., Liusina, E., Ivashkin, V. T., & Gluud, C. (2016). Ultrasonography for diagnosis of alcoholic cirrhosis in people with alcoholic liver disease. The Cochrane database of systematic reviews, 3(3), CD011602. https://doi.org/10.1002/14651858.CD011602.pub2
Peng, H., Deng, Z., Chen, X., Sun, Y., & Li, H. (2018). Major chemical constituents and antioxidant activities of different extracts from the peduncles of Hovenia acerba Lindl. International Journal of Food Properties, 21(1), 2135–2155.
Ramond, M. J., Poynard, T., Rueff, B., Mathurin, P., Théodore, C., Chaput, J. C., & Benhamou, J. P. (1992). A randomized trial of prednisolone in patients with severe alcoholic hepatitis. The New England journal of medicine, 326(8), 507–512. https://doi.org/10.1056/NEJM199202203260802
Ruhl, C. E., & Everhart, J. E. (2005). Joint effects of body weight and alcohol on elevated serum alanine aminotransferase in the United States population. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 3(12), 1260–1268. https://doi.org/10.1016/s1542-3565(05)00743-3
Seth, D., Hogg, P. J., Gorrell, M. D., McCaughan, G. W., & Haber, P. S. (2008). Direct effects of alcohol on hepatic fibrinolytic balance: implications for alcoholic liver disease. Journal of hepatology, 48(4), 614–627. https://doi.org/10.1016/j.jhep.2007.12.015
Singal, A. K., Bashar, H., Anand, B. S., Jampana, S. C., Singal, V., & Kuo, Y. F. (2012). Outcomes after liver transplantation for alcoholic hepatitis are similar to alcoholic cirrhosis: exploratory analysis from the UNOS database. Hepatology (Baltimore, Md.), 55(5), 1398–1405. https://doi.org/10.1002/hep.25544
Singal, A. K., Chaha, K. S., Rasheed, K., & Anand, B. S. (2013). Liver transplantation in alcoholic liver disease current status and controversies. World journal of gastroenterology, 19(36), 5953–5963. https://doi.org/10.3748/wjg.v19.i36.5953
Sofair, A. N., Barry, V., Manos, M. M., Thomas, A., Zaman, A., Terrault, N. A., Murphy, R. C., Stabach, N., Huie, S., Van Ness, G., Bell, B. P., & Bialek, S. (2010). The epidemiology and clinical characteristics of patients with newly diagnosed alcohol-related liver disease: results from population-based surveillance. Journal of clinical gastroenterology, 44(4), 301–307. https://doi.org/10.1097/MCG.0b013e3181b3f760
Stewart, S., Jones, D., & Day, C. P. (2001). Alcoholic liver disease: new insights into mechanisms and preventative strategies. Trends in molecular medicine, 7(9), 408–413. https://doi.org/10.1016/s1471-4914(01)02096-2
Stickel, F., & Hampe, J. (2012). Genetic determinants of alcoholic liver disease. Gut, 61(1), 150–159. https://doi.org/10.1136/gutjnl-2011-301239
Stickel, F., Hoehn, B., Schuppan, D., & Seitz, H. K. (2003). Review article: Nutritional therapy in alcoholic liver disease. Alimentary pharmacology & therapeutics, 18(4), 357–373. https://doi.org/10.1046/j.1365-2036.2003.01660.x
Stohs, S. J., & Hartman, M. J. (2015). Review of the Safety and Efficacy of Moringa oleifera. Phytotherapy research : PTR, 29(6), 796–804. https://doi.org/10.1002/ptr.5325
Strader, D. B., Bacon, B. R., Lindsay, K. L., La Brecque, D. R., Morgan, T., Wright, E. C., Allen, J., Khokar, M. F., Hoofnagle, J. H., & Seeff, L. B. (2002). Use of complementary and alternative medicine in patients with liver disease. The American journal of gastroenterology, 97(9), 2391–2397. https://doi.org/10.1111/j.1572-0241.2002.05993.x
Sussman, S., Dent, C. W., Skara, S., de Calice, P., & Tsukamoto, H. (2002). Alcoholic liver disease (ALD): a new domain for prevention efforts. Substance use & misuse, 37(14), 1887–1904. https://doi.org/10.1081/ja-120016223
Szabo, G., Aloman, C., Polyak, S. J., Weinman, S. A., Wands, J., & Zakhari, S. (2006). Hepatitis C infection and alcohol use: A dangerous mix for the liver and antiviral immunity. Alcoholism, clinical and experimental research, 30(4), 709–719. https://doi.org/10.1111/j.1530-0277.2006.00083.x
Teli, M. R., Day, C. P., Burt, A. D., Bennett, M. K., & James, O. F. (1995). Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet (London, England), 346(8981), 987–990. https://doi.org/10.1016/s0140-6736(95)91685-7
Tilg, H., Moschen, A. R., & Kaneider, N. C. (2011). Pathways of liver injury in alcoholic liver disease. Journal of hepatology, 55(5), 1159–1161. https://doi.org/10.1016/j.jhep.2011.05.015
WHO (2011)World Health Organization (WHO) Global Status Report on Alcohol and Health. Geneva
WHO (2014)World Health Organization (WHO) Global Status Report on Alcohol and Health. Geneva
Wu, D., & Cederbaum, A. I. (2005). Oxidative stress mediated toxicity exerted by ethanol-inducible CYP2E1. Toxicology and applied pharmacology, 207(2 Suppl), 70–76. https://doi.org/10.1016/j.taap.2005.01.057
Xiong, Y., Yang, Y., Yang, J., Chai, H., Li, Y., Yang, J., Jia, Z., & Wang, Z. (2010). Tectoridin, an isoflavone glycoside from the flower of Pueraria lobata, prevents acute ethanol-induced liver steatosis in mice. Toxicology, 276(1), 64–72. https://doi.org/10.1016/j.tox.2010.07.007
You, M., & Crabb, D. W. (2004). Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver. American journal of physiology. Gastrointestinal and liver physiology, 287(1), G1–G6. https://doi.org/10.1152/ajpgi.00056.2004
You, M., Fischer, M., Deeg, M. A., & Crabb, D. W. (2002). Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). The Journal of biological chemistry, 277(32), 29342–29347. https://doi.org/10.1074/jbc.M202411200
Zhang, R., Hu, Y., Yuan, J., & Wu, D. (2009). Effects of Puerariae radix extract on the increasing intestinal permeability in rat with alcohol-induced liver injury. Journal of ethnopharmacology, 126(2), 207–214. https://doi.org/10.1016/j.jep.2009.08.044
Zhu, H., Jia, Z., Misra, H., & Li, Y. R. (2012). Oxidative stress and redox signaling mechanisms of alcoholic liver disease: updated experimental and clinical evidence. Journal of digestive diseases, 13(3), 133–142. https://doi.org/10.1111/j.1751-2980.2011.00569.x